News & milestones
Read NOxy publication announcements, research milestones, and third-party coverage of nitric oxide in wound care.
In Podiatry Today, Dr. Windy Cole reviews nitric oxide biology and places NOxy’s published 400-patient pressure-ulcer analysis in clinical context, including its stage-specific findings and real-world study design.
Read articleThe peer-reviewed retrospective analysis matched 200 NODF-treated older adults with 200 historical standard-of-care controls and reported modeled 12-week healing of 63% and 34%, respectively.
Read articleSmartTRAK’s market outlook reviews the biological rationale for nitric oxide, the delivery challenge, clinical and commercial activity across the field, and NOxy’s development and intellectual-property position.
Read articleAn educational discussion of WOUND-Q and the role of validated patient-reported outcomes in measuring pain, function, treatment burden, and quality of life in chronic wound care.
Read articleNOxy Chairman Thomas L. Olds Jr. explains the company’s focus on moving chronic wound care from repeated management toward durable healing.
Read articleNOxy examines the clinical and economic burden of chronic wounds, the gap between products that manage wounds and treatments intended to promote healing, and the need for therapies that address multiple barriers to repair.
Read white paperThis paper reviews nitric oxide’s roles in wound healing, explains why delivering a short-lived gas to the wound surface is difficult, and describes the rationale for generating nitric oxide from a topical foam at the time of application.
Read white paperNOxy considers the patient and healthcare burden of chronic wounds, the field’s long emphasis on management, and the case for research aimed at therapies that actively support wound healing.
Read white paper
